Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Business oriented EU human cell and tissue product legislation will adversely impact Member States’ health care systems
Jean‐Paul Pirnay, A. Vanderkelen, Daniël De Vos, et al.
Cell and Tissue Banking (2013) Vol. 14, Iss. 4, pp. 525-560
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review
Anne-Floor J. de Kanter, Karin Jongsma, Marianne C. Verhaar, et al.
Tissue Engineering Part B Reviews (2022) Vol. 29, Iss. 2, pp. 167-187
Open Access | Times Cited: 41
Successful development and clinical translation of a novel anterior lamellar artificial cornea
Laura Rico‐Sánchez, Ingrid Garzón, Miguel González‐Andrades, et al.
Journal of Tissue Engineering and Regenerative Medicine (2019) Vol. 13, Iss. 12, pp. 2142-2154
Open Access | Times Cited: 60
Commercialization and regulation of regenerative medicine products: Promises, advances and challenges
Nima Beheshtizadeh, Maliheh Gharibshahian, Zahra Pazhouhnia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113431-113431
Open Access | Times Cited: 37
Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products
Natividad Cuende, Rachele Ciccocioppo, Miguel Forte, et al.
Cytotherapy (2022) Vol. 24, Iss. 7, pp. 686-690
Open Access | Times Cited: 29
Using Stem Cells to Grow Artificial Tissue for Peripheral Nerve Repair
K. S. Bhangra, Francesca Busuttil, James B. Phillips, et al.
Stem Cells International (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 60
Magistral Phage Preparations: Is This the Model for Everyone?
Jean‐Paul Pirnay, Gilbert Verbeken
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S360-S369
Open Access | Times Cited: 14
Cryostorage management of reproductive cells and tissues in ART: status, needs, opportunities and potential new challenges
Stefano Canosa, Roberta Maggiulli, Danilo Cimadomo, et al.
Reproductive BioMedicine Online (2023) Vol. 47, Iss. 3, pp. 103252-103252
Closed Access | Times Cited: 13
Regulatory challenges for the manufacture and scale-out of autologous cell therapies
Paul Hourd
StemBook (2014)
Open Access | Times Cited: 45
Participation in SoHO and ATMP public consultations: a fragmented institutional landscape
Michael Morrison, Valentin Brunel, Aurélie Mahalatchimy
Humanities and Social Sciences Communications (2025) Vol. 12, Iss. 1
Open Access
The Survey on Cellular and Engineered Tissue Therapies in Europe in 2012
Iván Martín, Hilary Ireland, Helen Baldomero, et al.
Tissue Engineering Part A (2014) Vol. 21, Iss. 1-2, pp. 1-13
Open Access | Times Cited: 39
Histological assessment of nanostructured fibrin‐agarose skin substitutes grafted in burnt patients. A time‐course study
Miguel Ángel Martín‐Piedra, Gloria Carmona, Fernando Campos, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 10
Phages and phage-borne enzymes as new antibacterial agents
Shawna McCallin, Zuzanna Drulis‐Kawa, Tristan Ferry, et al.
Clinical Microbiology and Infection (2023)
Closed Access | Times Cited: 9
Access to human tissues for research and product development
Jean‐Paul Pirnay, Étienne Baudoux, Olivier Cornu, et al.
EMBO Reports (2015) Vol. 16, Iss. 5, pp. 557-562
Open Access | Times Cited: 32
About ATMPs, SOPs and GMP: The Hurdles to Produce Novel Skin Grafts for Clinical Use
Fabienne Hartmann-Fritsch, Daniela Marino, Ernst Reichmann
Transfusion Medicine and Hemotherapy (2016) Vol. 43, Iss. 5, pp. 344-352
Open Access | Times Cited: 31
Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry
Jan Mačí, Petra MareÅ¡ová
Risk Management and Healthcare Policy (2022) Vol. Volume 15, pp. 71-91
Open Access | Times Cited: 14
Addressing Risks Derived From the Commodification of Substances of Human Origin: A European Proposal Applicable Worldwide
Natividad Cuende, Anna Vilarrodona, Elena Vuelta, et al.
Transplantation (2023) Vol. 107, Iss. 4, pp. 867-877
Open Access | Times Cited: 8
Global Regulatory Differences for Gene‐ and Cell‐Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation
D. Coppens, Marie L. De Bruin, Hubert G. M. Leufkens, et al.
Clinical Pharmacology & Therapeutics (2017) Vol. 103, Iss. 1, pp. 120-127
Open Access | Times Cited: 28
A Road Map to Commercialization of Cartilage Therapy in the United States of America
BanuPriya Sridharan, Blanka Sharma, Michael S. Detamore
Tissue Engineering Part B Reviews (2015) Vol. 22, Iss. 1, pp. 15-33
Open Access | Times Cited: 27
Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries
D. Coppens, Jarno Hoekman, Marie L. De Bruin, et al.
Cytotherapy (2020) Vol. 22, Iss. 10, pp. 592-600
Open Access | Times Cited: 22
Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology
Alexis Laurent, Nathalie Hirt‐Burri, Corinne Scaletta, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 20
Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care
Karim Al-Dourobi, Alexis Laurent, Lina Deghayli, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 201-201
Open Access | Times Cited: 17
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care
Alexis Laurent, Marina Fortes Rey, Corinne Scaletta, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 184-184
Open Access | Times Cited: 6
Early-stage bilayer tissue-engineered skin substitute formed by adult skin progenitor cells produces an improved skin structure in vivo
Qun Zhang, Jie Wen, Chang Liu, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Burn patient care lost in good manufacturing practices?
Gina Dimitropoulos, Paris Jafari, Anthony de Buys Roessingh, et al.
PubMed (2016) Vol. 29, Iss. 2, pp. 111-115
Closed Access | Times Cited: 17
Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs
Michèle Chemali, Alexis Laurent, Corinne Scaletta, et al.
Journal of Burn Care & Research (2021) Vol. 42, Iss. 5, pp. 911-924
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top